111 Inc ADR (YI)

NASD · Healthcare · Medical Distribution · China

111 Inc ADR is a micro cap company (market value under $300 million) in the Medical Distribution industry.

Intrinsic value, DCF valuation, financial health and value investing analysis for the 111 Inc ADR stock.

Our verdict on YI

Undervalued: intrinsic value $3.83 per share, market price $2.85, margin of safety 25.6% (as of 2026-10-30).

Its liquidation floor, current assets minus every liability, values the shares at $3.83; the price of $2.85 is 26% below that value.

Browse

Peers in Medical Distribution

All 11 Medical Distribution stocks

Is YI undervalued or overvalued?

YI is undervalued (as of the 2026-10-30 close). Its liquidation floor, current assets minus every liability, values the shares at $3.83; the price of $2.85 is 26% below that value.

What is the intrinsic value of YI?

$3.83 per share (as of the 2026-10-30 close), against a market price of $2.85. That is a margin of safety of 25.6%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.